22157.jpg
All the Information a Physician, Physician Assistant, Dietitian or Nurse Practitioner Needs to Set Up a Successful Weight Loss Practice in the United States with Key Financial Insights
December 01, 2022 04:03 ET | Research and Markets
Dublin, Dec. 01, 2022 (GLOBE NEWSWIRE) -- The "How To Set Up A Profitable Medical Weight Loss Program" report from Marketdata LLC has been added to ResearchAndMarkets.com's offering.The U.S....
22157.jpg
United States Profitable Medical Weight Loss Program Setup Guide 2022: Success Criteria, Diet Market Outlook, Program Components, Pricing, ACA's Preventative Care Benefit Opportunities, Franchises
June 03, 2022 04:58 ET | Research and Markets
Dublin, June 03, 2022 (GLOBE NEWSWIRE) -- The "How To Set Up A Profitable Medical Weight Loss Program" report from Marketdata LLC has been added to ResearchAndMarkets.com's offering.The U.S. medical...
22157.jpg
Overview of the $58 Billion U.S. Weight Loss Market 2022
March 23, 2022 06:13 ET | Research and Markets
Dublin, March 23, 2022 (GLOBE NEWSWIRE) -- The "The U.S. Weight Loss Market: 2022 Status Report & Forecast" report from Marketdata LLC has been added to ResearchAndMarkets.com's offering. The...
22157.jpg
United States Weight Loss & Diet Control Market: Health Clubs and Medical Weight Loss Contract by 37% and 27% During 2020
June 18, 2021 08:33 ET | Research and Markets
Dublin, June 18, 2021 (GLOBE NEWSWIRE) -- The "The U.S. Weight Loss & Diet Control Market" report from Marketdata LLC has been added to ResearchAndMarkets.com's offering. The U.S. weight loss...
22157.jpg
United States Weight Loss & Diet Control Market Report 2021-2025
March 26, 2021 06:43 ET | Research and Markets
Dublin, March 26, 2021 (GLOBE NEWSWIRE) -- The "The U.S. Weight Loss & Diet Control Market" report has been added to ResearchAndMarkets.com's offering. The U.S. weight loss market reached a...
Obalon_Logo_Teal_2c.jpg
Obalon Announces Third Quarter 2020 Financial Results
November 06, 2020 16:45 ET | Obalon Therapeutics, Inc.
SAN DIEGO, Nov. 06, 2020 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled...
Obalon_Logo_Teal_2c.jpg
Obalon Announces Consulting Agreement As Part of Strategy To Seek Coverage and Reimbursement for The Obalon Balloon System
August 13, 2020 07:00 ET | Obalon Therapeutics, Inc.
SAN DIEGO, Aug. 13, 2020 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (Nasdaq: OBLN), a weight loss solutions company with the first and only FDA-approved swallowable, gas-filled intragastric...
Obalon_Logo_Teal_2c.jpg
Obalon Announces Second Quarter 2020 Financial Results
July 30, 2020 06:38 ET | Obalon Therapeutics, Inc.
SAN DIEGO, July 30, 2020 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled...
Obalon_Logo_Teal_2c.jpg
Obalon Announces First Quarter 2020 Financial Results and Business Update
June 19, 2020 06:15 ET | Obalon Therapeutics, Inc.
SAN DIEGO, June 19, 2020 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (Nasdaq: OBLN), a weight loss solutions company with the first and only FDA-approved swallowable, gas-filled intragastric...
Obalon_Logo_Teal_2c.jpg
Obalon Announces Further Impacts Related To Covid-19 Crisis and Current Business Environment
May 11, 2020 08:30 ET | Obalon Therapeutics, Inc.
SAN DIEGO, May 11, 2020 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (“Obalon” or the “Company”) (NASDAQ:OBLN), a vertically integrated weight loss solutions company commercializing the first and...